Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Available safety data showed no increase in serious cardiovascular events during 68 weeks of treatment
Lilly is also working towards an obesity treatment form of tirzepatide, with trials currently underway to evaluate its weight loss effects
Key Player Analysis Bachem Holding AG Novo Nordisk A/S Eli Lilly and Company HEC Pharma Co
Lycium barbarum polysaccharide alleviate cadmium-induced mitochondrial dysfunction mediated pyroptosis in duck liver
Zhang H, Sturchler E, Zhu J, et al
Mice were randomly assigned to treatment and control groups
US$ 24.03
US$ 21.58
US$ 24.42
US$ 22.80
US$ 22.86
US$ 20.22
